BOSTON–(BUSINESS WIRE)–April 21, 2022–
The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced the winners of the 2022 Henri Termeer Transatlantic Connections Award. of the second annual award will be recognized during a presentation to the Innovate for health conference which will take place on April 21, 2022 in the Netherlands.
This year’s winners of the Henri Termeer Transatlantic Connections Award are: Kasper Roet, of QurAlis Corporation and Koenraad Wiedhaup, of Leyden Labs; Information on the winners of the 2021 Henri Termeer Transatlantic Connections Prize is available here.
“We are delighted to honor the winners of the 2022 Henri Termeer Transatlantic Connections Award, Kasper Roet and Koenraad Wiedhaup, who both deserve this award because of their outstanding career paths and commitment to the ideals of Henri Termeer,” said said Belinda Termeer, President. and co-founder of the Termeer Foundation. “Even at this early stage in their careers, they have shown a great ability to combine leadership and innovation within their companies as they pursue distinct scientific paths towards the development of breakthrough drugs.”
The Henri Termeer Transatlantic Connections Prize was created through an agreement in July 2019 between the Massachusetts Office of International Trade and Investment and the Dutch Ministry of Economic Affairs and Climate Policy, which created and signed a Memorandum of Understanding. agreement laying the foundations for a Massachusetts – Netherlands Transatlantic Partnership for Life Sciences. Signatories included Top Sector Life Sciences & Health (Health-Holland), MassBio, HollandBIO and the Henri A. Termeer Tribute Committee; all of whom have agreed to provide support and organize activities to promote transatlantic collaboration between the two biotech ecosystems.
“The Transatlantic Connections award creates significant opportunities for its winners to network, learn and eventually collaborate with life science professionals in two of the most important life science sectors,” said Hans Schikan, Fellow of the Board of Directors of Health-Holland and member of the Henri Termeer. Transatlantic Connections Award Steering Committee. “Over the next year as award winners and beyond as Termeer Fellows, this year’s awardees will be offered a variety of opportunities to enhance their knowledge of the global life sciences industry. and plant the seeds for the company’s future success.”
Each year, the Termeer Foundation and Health-Holland select two emerging life science entrepreneurs, one in Massachusetts and one in the Netherlands, who conduct innovative biomedical research activities and whose programs have the potential strengthen transatlantic relations between the two life sciences regions. . Applicants are selected based on their initial entrepreneurial success in building a life sciences business that meets certain scientific and financial criteria, demonstrates a keen interest in mentoring other young entrepreneurs, and possesses a willingness to s become more involved in the programs of the Termeer Foundation. Winners also receive Fellowship status within the Termeer Foundation, which includes access to experienced healthcare mentors, networking with other peer entrepreneurs, and recognition at the annual awards celebration. Termeer scholarship holders. Recipients are invited to spend a week visiting their colleague’s company and the local biotechnology sector, and participating in other learning, networking and cultural events there.
“When QurAlis was created, we recognized that even at an early stage, the development of drugs to treat neurodegenerative diseases had no boundaries or geographical limitations,” said Kasper Roet, co-founder and CEO of QurAlis. . “Being selected to receive the Transatlantic Connections award is not only an honor, but a great platform from which to build these all-important relationships outside of our industry.”
The biotechnology sectors of Greater Boston and the Netherlands represent two of the world’s most prolific centers for biomedical research. Boston and Cambridge are home to about 1,400 biotech companies; ranging from small, emerging start-ups to larger, more established biopharmaceutical companies. Cambridge’s Kendall Square is the heart of this area and home to a large concentration of life sciences companies, with over 120 located within the Square’s small footprint. The highly collaborative Dutch life sciences and healthcare community includes 3,100 life science R&D companies, 420 biopharmaceutical companies, 65,000 pharmaceutical employees and a medical technology market of 4.7 Billions of Euro’s. Life science companies in the Netherlands enjoy countless opportunities for growth and collaboration.
“Receiving the Termeer Transatlantic Connections award and recognition for our company’s vision is a wonderful compliment to the work we have done so far,” said Koenraad Wiedhaup, Founder and CEO of Leyden Labs. “I am thrilled to be part of the link between the biotech ecosystems of Massachusetts and the Netherlands created by Henri Termeer and look forward to participating in future programs with my award-winning colleague.”
About the Termeer Foundation
Building on the bold legacy of Henri Termeer, a pioneer in breakthrough treatments for rare diseases, the Termeer Foundation connects life science innovators and catalyzes the creation of new medicines. The Foundation’s network of emerging and established healthcare innovators cultivates the leaders of tomorrow and leverages their collective expertise to solve complex problems in drug development and accessibility. The Foundation also integrates its network with academic institutions, non-profit organizations, regulatory agencies and other organizations in the global healthcare ecosystem to provide expert advice, drive innovation, eliminate obstacles to progress and ultimately connecting the world of healthcare until every patient has a cure. Visit us at www.termeerfoundation.org or on LinkedIn @TermeerFoundation.
Show source version on businesswire.com:https://www.businesswire.com/news/home/20220421005558/en/
CONTACT: Erica Mawby-Roche
KEYWORD: EUROPE USA NETHERLANDS NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE PHARMACEUTICAL RESEARCH
SOURCE: The Termeer Foundation
Copyright BusinessWire 2022.
PUBLISHED: 04/21/2022 08:00 AM / DISK: 04/21/2022 08:02 AM